Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

38.78
-0.4000-1.02%
Volume:1.25M
Turnover:48.26M
Market Cap:45.18B
PE:64.63
High:39.18
Open:38.80
Low:38.25
Close:39.18
52wk High:40.79
52wk Low:18.83
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.86
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.83
PE(LYR):32.05

Loading ...

Feb 10, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 25, 2021

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Aug 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 06, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jun 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2020

Major Issues Report

8-K - Current report